mAbXmise OTDM1
mAbXmise – Monoclonal antibodies quantification Kit Multiplex Nivolumab, Pembrolizumab, Trastuzumab, Cetuximab, Bevacizumab, Ipilimumab, Rituximab
IVD generalIVDDOn the marketAnimal tissuesHuman tissuesKitProfessional testingReagent
- Manufacturer
- Promise proteomics
- Manufacturer SRN
- FR-MF-000027377
- UDI-DI
- 03770024131024
- Basic UDI-DI
- B-03770024131024
- Reference
- OTDM1
- EMDN
- W0102080704
- EMDN description
- RITUXIMAB
- First on market country
- France
- Authorised representative
- -
- Last updated
- 19.07.2026 20:47